Keeping You Informed

The ability to use circulating tumor DNA (ctDNA) to guide surgical decision-making following neoadjuvant chemotherapy was explored in a presentation by researchers at the 2025 ASCO Annual Meeting.

Lack of access to healthy food is a threat to the lives of cancer survivors—a significant and often overlooked factor affecting their long-term health outcomes.

A study to find the right dose of aspirin to reduce the risk of cancer in some patients has found the smallest amount works just as well as larger ones, according to a leading researcher.

Returning to work after a cancer diagnosis presents unique challenges, especially for those who work in physically demanding jobs. While many cancer survivors want or need to keep working during treatment, they often face a mismatch between their physical or cognitive capabilities, and their job demands.

In 2024, COA’s Patient Advocacy Network (CPAN) provided advocacy, education, and engagement opportunities in multiple ways.

In 2023, COA’s Patient Advocacy Network (CPAN) provided advocacy, education, and engagement opportunities in multiple ways.

While the new year is always filled with energy and enthusiasm, it is also important to reflect on the impact of our advocacy accomplishments in 2022.

A Note from the Director of Patient Advocacy & Education .....

Advocacy Chats – Educational Conversations on Cancer Policy and Advocacy .....

Upcoming Advocacy Chats – Educational Conversations on Cancer Advocacy and .....